The MI-BET study will evaluate whether imaging, biomarkers, and clinical data can help tailor radioligand therapy based on individual patient response rather than a fixed treatment schedule.
The company showcased new PET and SPECT technologies, imaging software, and radiopharmaceuticals aimed at supporting theranostics, quantitative imaging, and nuclear medicine workflows.
New milestones in Asia-Pacific and North America reflect the growing use of spectral imaging in clinical and research settings.
The solution identifies and categorizes positive findings across lung, pleura, heart, bone, and hardware regions to support clinical decision-making.
Read More
GE HealthCare’s updated LOGIQ portfolio targets growing imaging volumes with automated abdominal tools, ultrasound-guided fat fraction, and expanded third-party AI integration.
Read More
Clearances cover a sealed-magnet 1.5T system, a new 3T platform, and an AI-driven workflow ecosystem aimed at improving efficiency and addressing operational constraints.
Read More
The system is built to address limitations of using adult-sized MRI scanners for newborn imaging.
Read More
The review traces how hardware, scanning techniques, and reconstruction advances—including photon-counting CT—have enabled large dose reductions while maintaining diagnostic performance.
Read More